What Quality by Design Delivers for Swiss Pharma TeamsUntitledA Science-Based Route to Consistent Quality
Quality by Design Training in Switzerland gives pharmaceutical and biopharmaceutical professionals a systematic, science-based way to build quality into a product from the design stage rather than testing it in at the end. Quality by Design (QbD) is the approach set out in the ICH Q8, Q9, Q10 and Q11 guidelines and increasingly expected by regulators such as the FDA and EMA in modern development and manufacturing submissions. Over one focused day, you learn to apply the core QbD toolkit: the Quality Target Product Profile (QTPP), Critical Quality Attributes (CQAs), risk assessment, Design of Experiments (DoE), the design space and the control strategy. Hands-on exercises use realistic development scenarios, so you leave able to apply each tool at the bench, not just describe it. The course suits formulation and analytical scientists, process development engineers, QA and regulatory affairs specialists across Switzerland's Basel and Lake Geneva clusters who want to work the way ICH guidelines and health authorities now expect.










